HKSE - Delayed Quote HKD

WEIGAO GROUP (1066.HK)

5.990
+0.080
+(1.35%)
At close: 4:08:36 PM GMT+8

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
NameTitlePayExercisedYear Born
Mr. Jing Long Executive Chairman of the Board & Compliance Officer 3.15M -- 1975
Mr. Rinan Cong CEO & Executive Director 2.23M -- 1981
Mr. Junqiang Lu Executive Director 1.93M -- 1974
Ms. Xia Yan Non-Executive Director -- -- 1976
Mr. Daoming Wang Executive Director 727.92k -- 1980
Mr. Xue Feng Wu Chief Financial Officer -- -- 1978
Ms. Miu Ling Wong ACIS, FCIS, FCS Company Secretary -- -- 1969

WEIGAO GROUP

1 Weigao Road
Torch Hight-Tech Industrial Development Zone
Weihai, 264210
China
86 400 646 6666 https://www.weigaogroup.com
Sector: 
Healthcare
Full Time Employees: 
12,719

Description

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company's medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and orthopedic products comprise spine, joint, trauma, sports medicine, bone repair material, and spinal endoscope products, as well as orthopedic devices, PRP treatment consumables, and negative pressure drainage consumables. Its pharma packaging products consist of prefilled drug delivery systems, pharmaceutical packaging consumables, automatic drug delivery systems, and pre-filled syringes; interventional products include offers tumor, vascular, and nursing interventions; and blood management products comprise whole blood collection consumables and blood transfusion equipment. The company also provides finance leasing and factoring services; medical PVC granules, plastic packing bags, and carton boxes; medical polymer materials and products; injection puncture instruments; computer technical services; consulting services; and X-ray based irradiation machines. In addition, it sells electronic products. The company was founded in 1988 and is based in Weihai, the People's Republic of China.

Corporate Governance

WEIGAO GROUP’s ISS Governance QualityScore as of May 1, 2025 is 9. The pillar scores are Audit: 6; Board: 3; Shareholder Rights: 10; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 26, 2025 at 10:59 AM UTC

WEIGAO GROUP Earnings Date

June 2, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events

Related Tickers